Learn more →
Back to Expert Scholars
Translational Medicine / 转化医学Cancer RNA Therapeutics, siRNA

Stanley Crooke

MD, PhD

🏢Ionis Pharmaceuticals🌐USA

Founder and Chair, n-Lorem Foundation; Founder, Ionis Pharmaceuticals

100
h-index
0
Key Papers
0
Key Contributions

👥Biography 个人简介

Stanley Crooke founded Ionis Pharmaceuticals (formerly Isis) and pioneered antisense oligonucleotide therapeutics, an RNA-targeted modality that complements siRNA. His work has enabled multiple approved ASO drugs and oncology applications. He founded the n-Lorem Foundation to provide ASOs for ultra-rare disease patients.

Share:

🧪Research Fields 研究领域

antisense oligonucleotides
ASO chemistry
RNA therapeutics
oncogene knockdown
cancer ASO

🎓Key Contributions 主要贡献

Representative Works 代表性著作

📄Data Sources 数据来源

Last updated: 2026-04-01 | All information from publicly available academic sources

关注 Stanley Crooke 的研究动态

Follow Stanley Crooke's research updates

留下邮箱,当我们发布与 Stanley Crooke(Ionis Pharmaceuticals)相关的新研究或访谈时,我们会通知你。

我们不会泄露你的信息,也不会发送无关内容。随时可以退订。

Explore More Experts

Discover the researchers shaping the future of cancer treatment